Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say

08.05.25 16:00 Uhr

For the quarter ended March 2025, Zai Lab Limited Unsponsored ADR (ZLAB) reported revenue of $106.49 million, up 22.2% over the same period last year. EPS came in at -$0.45, compared to -$0.55 in the year-ago quarter.The reported revenue represents a surprise of -9.06% over the Zacks Consensus Estimate of $117.09 million. With the consensus EPS estimate being -$0.50, the EPS surprise was +10.00%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Zai Lab Limited performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Product Revenue- ZEJULA: $49.53 million versus the three-analyst average estimate of $48.32 million. Product Revenue- OPTUNE: $11.36 million versus the three-analyst average estimate of $8.35 million. Product Revenue- VYVGART: $18.11 million compared to the $31.75 million average estimate based on three analysts. Product Revenue- NUZYRA: $15.12 million versus the three-analyst average estimate of $14.39 million. Product Revenue- QINLOCK: $8.51 million versus the three-analyst average estimate of $8.21 million. View all Key Company Metrics for Zai Lab Limited here>>>Shares of Zai Lab Limited have returned +4.8% over the past month versus the Zacks S&P 500 composite's +11.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Zai Lab Limited Unsponsored ADR (ZLAB): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Zai Lab und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Zai Lab

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Zai Lab

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Zai Lab Ltd Unsponsored American Deposit Receipt Repr 1 Sh

Wer­bung